While biotech increasingly adopts AI for R&D, manufacturing bottlenecks constrain health innovation. AI and robotics have the ...

Bayer is the world's 25th largest pharmaceutical company. New Albany will be its first manufacturing site of this kind in ...

A Bay Area biotech company appears to be one major step closer to receiving final federal approval for its groundbreaking ...

Jared Holz, Mizuho healthcare sector specialist, joins 'Fast Money' to talk rising rates and how the biotech sector is ...

VitroVivo Biotech LLC, a Maryland-based provider of histology and molecular histopathology products and laboratory services, is expanding access to specialized tissue-based research support through ...

A 100% tariff on imported drugs just expanded to cover every drugmaker in the country, yet the biotech market's most closely ...

Nubank early-stage talks could value Monzo at £8bn-£10bn, more than double its £4.5bn October 2024 share-sale valuation; a ...

Biotech and pharma organizations are adopting AI at rapid pace, focusing on R&D, and precision medicine. As challenges emerge ...

Aviceda Therapeutics has shut down after AVD-104 failed a Phase 2b trial vs. Astellas' Izervay for geographic atrophy, ...

Chinese-designed drugs now account for roughly half the global pipeline. STAT's Jason Mast traveled to Shanghai to get an up-close look at the competition that's making American's nervous.

Novonesis has completed its acquisition of Australian biotechnology company MicroBioGen, strengthening its expertise in yeast ...